Oxymorphone hydrochloride
Active substance: oxymorphone
TABLET, FILM COATED, EXTENDED RELEASE · OXYMORPHONE HYDROCHLORIDE 20 mg/1
United StatesActive
Marketing holder: Amneal Pharmaceuticals of New York LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- OXYMORPHONE HYDROCHLORIDE · 20 mg/1
Import and control
Control by country
- United StatescontrolledSchedule: CII
Source: openFDA NDC · record 01a1208c-4898-78ef-9ee9-59ef123842f0,01a1208c-5b8f-775f-b3f3-8c5563c576f8,01a1208c-a95b-7199-bcdc-251bd39083ea,01a1208f-8377-7d4b-98c8-98c9cb815311,01a1208f-9811-7000-b5cf-30c4d3ffef8e;count=27 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0115-1233
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CII
- Route
- ORAL
Sources
- product · openFDA NDC · 0115-1233 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0115-1233 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0115-1233 · Verified 2026-10-09 · open in source